EMEA-003040-PIP01-21
Key facts
Active substance |
Izaflortaucipir (18F)
|
Therapeutic area |
Neurology
|
Decision number |
P/0432/2021
|
PIP number |
EMEA-003040-PIP01-21
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
Life Molecular Imaging GmbH
Email: gra@life-mi.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|